Pertuzumab in HER2+ breast cancer
Gunter von Minckwitz
Diversity of cancer patient concerns revealed through Holistic Needs Assessment
Keith Mitchell et al.
The impact of TRK inhibitor LOXO-101 (larotrectinib) on patients with TRK fusion cancers
Combining agents to improve response rates in genitourinary cancer
Andrea B. Apolo
Genomic aberrations in prostate cancer